La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « drugs »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
drug < drugs < drying  Facettes :

List of bibliographic references indexed by drugs

Number of relevant bibliographic references: 26.
[0-20] [0 - 20][0 - 26][20-25][20-40]
Ident.Authors (with country if any)Title
000274 (2016) Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada]Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease.
000363 (2016) Martin J. Brodie ; Frank Besag ; Alan B. Ettinger ; Marco Mula ; Gabriella Gobbi ; Stefano Comai ; Albert P. Aldenkamp ; Bernhard J. SteinhoffEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
000519 (2015) Ulf Ziemann [Allemagne] ; Janine Reis [Allemagne] ; Peter Schwenkreis [Allemagne] ; Mario Rosanova [Italie] ; Antonio Strafella [Canada] ; Radwa Badawy [Australie] ; Florian Müller-Dahlhaus [Allemagne]TMS and drugs revisited 2014.
000750 (2015) Joe Kakish ; Dongsoo Lee ; Jeremy S. LeeDrugs That Bind to α-Synuclein: Neuroprotective or Neurotoxic?
000888 (2014) Omid Tavassoly [Canada] ; Joe Kakish [Canada] ; Sergiy Nokhrin [Canada] ; Oleg Dmitriev [Canada] ; Jeremy S. Lee [Canada]The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease.
000941 (2014) Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada]Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
000A70 (2014) Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. FoxEmerging drugs for levodopa-induced dyskinesia.
000D32 (2013) Saranya Kittanakom [Canada] ; Anthony Arnoldo [Canada] ; Kevin R. Brown [Canada] ; Iain Wallace [Canada] ; Tada Kunavisarut [Thaïlande] ; Dax Torti [Canada] ; Lawrence E. Heisler [Canada] ; Anuradha Surendra [Canada] ; Jason Moffat [Canada] ; Guri Giaever [Canada] ; Corey Nislow [Canada]Miniature Short Hairpin RNA Screens to Characterize Antiproliferative Drugs
001082 (2013) Mee-Sook Song [Canada] ; Dmitriy Matveychuk [Canada] ; Erin M. Mackenzie [Canada] ; Maryana Duchcherer [Canada] ; Darrell D. Mousseau [Canada] ; Glen B. Baker [Canada]An update on amine oxidase inhibitors: Multifaceted drugs
001206 (2012) Russell C. Callaghan [Canada] ; James K. Cunningham ; Jenna Sykes ; Stephen J. KishIncreased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs.
001515 (2012) Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada]Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs
002219 (2008) Jeffrey A. Lieberman ; Frank P. Bymaster ; Herbert Y. Meltzer ; Ariel Y. Deutch ; Gary E. Duncan ; Christine E. Marx ; June R. Aprille ; Donard S. Dwyer ; Xin-Min Li ; Sahebarao P. Mahadik ; Ronald S. Duman ; Joseph H. Porter ; Josephine S. Modica-Napolitano ; Samuel S. Newton ; John G. CsernanskyAntipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
002733 (2006) A J Espay ; F. Morgante ; C. Gunraj ; R. Chen ; A E LangMirror movements in Parkinson's disease: effect of dopaminergic drugs
002B89 (2004) Tom H. Johnston [Canada] ; Jonathan M. BrotchieDrugs in development for Parkinson's disease.
002E51 (2003) Stanley Nattel [Canada] ; James Kneller [Canada] ; Renqiang Zou [Canada] ; L. Joshua Leon [Canada]Mechanisms of Termination of Atrial Fibrillation by Class I Antiarrhythmic Drugs:
002E67 (2003) Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis]Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies
003122 (2001) H. MollerAntiparkinsonian drugs and "sleep attacks".
003334 (2001) Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël]Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression
003588 (2000) M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada]Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS
003759 (1999) Stanley Nattel [Canada] ; Bramah N. Singh [États-Unis]Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions
003868 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "drugs" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "drugs" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    drugs
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022